why choose us

First received: January 09, 2023

Clinical Trial: Long-term Extension Study of Ligelizumab in Food Allergy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Food Allergy

Study Type: INTERVENTIONAL


Official Title: A Three-year, Multi-center, Double-blind, Extension Study to Evaluate the Long-term Safety and Efficacy of Ligelizumab in Patients Who Completed Ligelizumab's Phase III Studies in Food Allergy

Brief Summary: This is an extension study to evaluate the long-term safety and efficacy of ligelizumab in particiants who have completed a ligelizumab Phase III study in food allergy.

Read more